
|Videos|July 27, 2016
Barbara Van Husen on Improvements in MPN Research
Author(s)Barbara Van Husen
Barbara Van Husen, president of the MPN Research Foundation, discusses how after the discovery of the JAK2 mutation in 2005, MPN research and treatment advances proliferated. Now, Van Husen says, it is one of the most active areas of hematological research
Advertisement
Barbara Van Husen, president of the MPN Research Foundation, discusses how after the discovery of the JAK2 mutation in 2005, MPN research and treatment advances proliferated. Now, Van Husen says, it is one of the most active areas of hematological research.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
2
What Breast Cancer Survivors Should Know About Weight Loss and Long-Term Health
3
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
4
Etentamig Improves Responses and Progression-Free Survival in Relapsed Multiple Myeloma
5




